
Esperion Therapeutics ESPR
$ 2.87
-5.51%
Quarterly report 2025-Q3
added 11-06-2025
Esperion Therapeutics Current Ratio 2011-2026 | ESPR
Annual Current Ratio Esperion Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.469 | 0.311 | 0.434 | 0.66 | 3.68 | 3.2 | 2.22 | 6.15 | 13.7 | 38.1 | 19.4 | 14.4 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 38.1 | 0.311 | 8.57 |
Quarterly Current Ratio Esperion Therapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.45 | 0.44 | 0.43 | 0.46 | 0.51 | 0.56 | 0.35 | 0.39 | 0.43 | 0.43 | 0.52 | - | 0.58 | 0.66 | 0.38 | 0.48 | 0.51 | 0.79 | 0.79 | 0.79 | 0.79 | 1.1 | 1.1 | 1.1 | 1.1 | 2.23 | 2.23 | 2.23 | 2.23 | 8.38 | 8.38 | 8.38 | 8.38 | 14.8 | 14.8 | 14.8 | 14.8 | 35.6 | 35.6 | 35.6 | 35.6 | 14.7 | 14.7 | 14.7 | 14.7 | 18.6 | 18.6 | 18.6 | 18.6 | 0.3 | 0.3 | 0.3 | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 35.6 | 0.3 | 7.71 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.02 | - | 2.43 % | $ 254 M | ||
|
Adagene
ADAG
|
2.3 | $ 1.9 | -3.11 % | $ 107 M | ||
|
Acorda Therapeutics
ACOR
|
1.61 | - | -24.86 % | $ 820 K | ||
|
Aeterna Zentaris
AEZS
|
1.6 | - | 5.93 % | $ 314 M | ||
|
Alterity Therapeutics Limited
ATHE
|
7.02 | $ 3.31 | -4.06 % | $ 7.96 B | ||
|
AgeX Therapeutics
AGE
|
1.81 | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
1.34 | - | -13.47 % | $ 169 M | ||
|
Aeglea BioTherapeutics
AGLE
|
6.71 | - | - | $ 1.01 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.87 | $ 25.87 | -0.79 % | $ 1.25 B | ||
|
Midatech Pharma plc
MTP
|
2.29 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | ||
|
Akero Therapeutics
AKRO
|
10.9 | - | - | $ 3.67 B | ||
|
Aptose Biosciences
APTO
|
0.69 | - | -45.71 % | $ 1.2 M | ||
|
Aravive
ARAV
|
1.21 | - | -13.39 % | $ 1.45 M | ||
|
Athira Pharma
ATHA
|
4.22 | - | - | $ 269 M | ||
|
Akouos
AKUS
|
6.18 | - | 0.23 % | $ 488 M | ||
|
AVROBIO
AVRO
|
15.9 | - | 1083.1 % | $ 745 M | ||
|
Applied Molecular Transport
AMTI
|
2.31 | - | - | $ 10.1 M | ||
|
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
0.918 | $ 215.29 | 4.59 % | $ 5 B | ||
|
BioNTech SE
BNTX
|
7.22 | $ 105.97 | -2.78 % | $ 27.2 B | ||
|
ARCA biopharma
ABIO
|
28.7 | - | 1052.0 % | $ 415 M | ||
|
Aytu BioScience
AYTU
|
1.47 | $ 2.71 | 1.88 % | $ 17 M | ||
|
Acasti Pharma
ACST
|
13.4 | - | 4.01 % | $ 150 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
2.73 | $ 64.74 | 1.41 % | $ 8.66 B | ||
|
Brickell Biotech
BBI
|
5.28 | - | -5.38 % | $ 6.06 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
2.76 | $ 3.96 | -1.0 % | $ 8.62 B | ||
|
BeiGene, Ltd.
BGNE
|
2.29 | - | 0.49 % | $ 251 B | ||
|
Burford Capital Limited
BUR
|
2.14 | $ 9.63 | -0.93 % | $ 1.56 B | ||
|
Ayala Pharmaceuticals
AYLA
|
6.43 | - | - | $ 7.46 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
1.16 | - | -15.15 % | $ 60.3 M | ||
|
AIkido Pharma
AIKI
|
6.48 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
2.39 | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
2.47 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
0.41 | - | 2.71 % | $ 14 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.32 | - | -9.72 % | $ 5.89 M | ||
|
Alpine Immune Sciences
ALPN
|
2.67 | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
22.6 | - | 4.14 % | $ 49.1 M | ||
|
BioLineRx Ltd.
BLRX
|
1.53 | $ 2.97 | 3.12 % | $ 908 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.41 | - | -11.43 % | $ 502 K | ||
|
Biogen
BIIB
|
2.47 | $ 164.87 | 0.27 % | $ 24 B | ||
|
Bio-Path Holdings
BPTH
|
1.16 | - | - | $ 100 K | ||
|
BioVie
BIVI
|
8.46 | $ 1.23 | 2.07 % | $ 1.82 M | ||
|
Baudax Bio
BXRX
|
0.293 | - | 0.59 % | $ 63 K | ||
|
Calithera Biosciences
CALA
|
4.13 | - | -10.95 % | $ 876 K | ||
|
Arena Pharmaceuticals
ARNA
|
10.8 | - | -6.81 % | $ 3.04 B | ||
|
Athersys
ATHX
|
2.38 | - | 3.77 % | $ 22.4 M | ||
|
Cara Therapeutics
CARA
|
1.83 | - | -3.03 % | $ 260 M | ||
|
Avenue Therapeutics
ATXI
|
3.27 | - | -52.27 % | $ 4.45 M |